Cite
Safety of combining thoracic radiation therapy with concurrent versus sequential immune checkpoint inhibition
MLA
Abraham J. Wu, et al. “Safety of Combining Thoracic Radiation Therapy with Concurrent versus Sequential Immune Checkpoint Inhibition.” Advances in Radiation Oncology, vol. 3, July 2018, pp. 391–98. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....14e71d0ab118dea45cc1bca42dd8055a&authtype=sso&custid=ns315887.
APA
Abraham J. Wu, R. Dick-Godfrey, Andrew J. Plodkowski, Christopher A. Barker, Donata von Reibnitz, Zhigang Zhang, Robert M. Samstein, Jamie E. Chaft, Andreas Rimner, Kelly Panchoo, Weiji Shi, & Matthew D. Hellmann. (2018). Safety of combining thoracic radiation therapy with concurrent versus sequential immune checkpoint inhibition. Advances in Radiation Oncology, 3, 391–398.
Chicago
Abraham J. Wu, R. Dick-Godfrey, Andrew J. Plodkowski, Christopher A. Barker, Donata von Reibnitz, Zhigang Zhang, Robert M. Samstein, et al. 2018. “Safety of Combining Thoracic Radiation Therapy with Concurrent versus Sequential Immune Checkpoint Inhibition.” Advances in Radiation Oncology 3 (July): 391–98. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....14e71d0ab118dea45cc1bca42dd8055a&authtype=sso&custid=ns315887.